In a retrospective study that included 17 ACC patients, a Ki-67/MIB-1 labeling index of 7% or higher was associated with shorter disease-free survival durations (p = 0.0037) [35]. The gene discussed is MKI67; the disease is adrenal cortex carcinoma.